Monitoring nevirapine-based programmes for prevention of mother-to-child transmission of HIV-1

Lancet. 2003 Aug 23;362(9384):667. doi: 10.1016/S0140-6736(03)14172-4.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Antibodies, Viral / analysis
  • Child
  • Developed Countries / statistics & numerical data
  • Female
  • Fetal Blood / chemistry
  • Fetal Blood / immunology
  • HIV Infections / drug therapy
  • HIV Infections / prevention & control*
  • HIV Infections / transmission*
  • HIV-1* / immunology
  • Humans
  • Infectious Disease Transmission, Vertical / prevention & control*
  • Nevirapine / therapeutic use*
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy*
  • Program Evaluation / methods
  • Zambia

Substances

  • Anti-HIV Agents
  • Antibodies, Viral
  • Nevirapine